Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$31.42 - $58.26
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Last Price
Market Cap | $2.62B |
EV | $2.18B |
Shares Outstanding | 63.38M |
Beta | 1.31 |
Analyst Rating | BUY |
Analyst Target Price | $78.08 |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | - |
EPS | 38.70% |
Operating Cash Flow | -40.30% |
Free Cash Flow | - |
Revenue | - |
EPS | -25.40% |
Operating Cash Flow | -25.20% |
Free Cash Flow | -27.20% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | -57.94% |
ROCE 2024 | -25.24% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
MoonLake Immunotherapeutics
MLTX
Sector
Healthcare
Industry
Biotechnology
CEO
da Silva, Jorge
Employees
100
Website
www.moonlaketx.comIPO Date
2020-10-20
Headquarters
Dorfstrasse 29, Zug, Zug, 6300, Switzerland
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved